CSIRO, Monash University and Monash Health Translation Precinct (MHTP[1]) have launched a new translational medical technology (medtech) research facility called M2 to help small and medium enterprises (SMEs) in the sector transition new discoveries from the bench to prototyping, pre-clinical testing, industry evaluation and commercialisation.
This infrastructure is supported by the Science and Industry Endowment Fund (SIEF). It is expected to accelerate the achievement of breakthroughs in life-changing medicine, including medical devices, vaccines and cell therapies.
Australia has more than 500 companies working in the Medical Technologies and Pharmaceuticals (MTP) sector. Many of these are SMEs, which might not have the resources to make the expensive, time consuming transition from prototype to clinically tested product.
Read More:
This infrastructure is supported by the Science and Industry Endowment Fund (SIEF). It is expected to accelerate the achievement of breakthroughs in life-changing medicine, including medical devices, vaccines and cell therapies.
Australia has more than 500 companies working in the Medical Technologies and Pharmaceuticals (MTP) sector. Many of these are SMEs, which might not have the resources to make the expensive, time consuming transition from prototype to clinically tested product.
Read More:
No comments:
Post a Comment